LncRNA UCA1 Promotes Development of Gastric Cancer Via the MiR-145/MYO6 Axis

Overview

Journal Cell Mol Biol Lett

Publisher Biomed Central

Specialties Biochemistry
Cell Biology
Molecular Biology

Date 2021 Jul 9

PMID 34238213

Citations 19

Authors

An Yang

Xin Liu

Ping Liu

Yunzhang Feng

Hongbo Liu

Shen Gao

Limin Huo

Xinyan Han

Jurong Wang

Wei Kong

Affiliations

Soon will be listed here.

Abstract

Background: Long noncoding RNA (lncRNA), urothelial carcinoma-associated 1 (UCA1) is aberrantly expressed in multiple cancers and has been verified as an oncogene. However, the underlying mechanism of UCA1 in the development of gastric cancer is not fully understood. In the present study, we aimed to identify how UCA1 promotes gastric cancer development.

Methods: The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) data were used to analyze UCA1 and myosin VI (MYO6) expression in gastric cancer. Western blot and quantitative real-time PCR (QPCR) were performed to test the expression level of the UCA1/miR-145/MYO6 axis in gastric cancer cell lines and tissues. The roles of the UCA1/miR-145/MYO6 axis in gastric cancer in vitro and in vivo were investigated by CCK-8 assay, flow cytometry, siRNAs, immunohistochemistry, and a mouse xenograft model. The targeted relationship among UCA1, miR-145, and MYO6 was predicted using LncBase Predicted v.2 and TargetScan online software, and then verified by luciferase activity assay and RNA immunoprecipitation.

Results: UCA1 expression was higher but miR-145 expression was lower in gastric cancer cell lines or tissues, compared to the adjacent normal cell line or normal tissues. Function analysis verified that UCA1 promoted cell proliferation and inhibited cell apoptosis in the gastric cancer cells in vitro and in vivo. Mechanistically, UCA1 could bind directly to miR-145, and MYO6 was found to be a downstream target gene of miR-145. miR-145 mimics or MYO6 siRNAs could partly reverse the effect of UCA1 on gastric cancer cells.

Conclusions: UCA1 accelerated cell proliferation and inhibited cell apoptosis through sponging miR-145 to upregulate MYO6 expression in gastric cancer, indicating that the UCA1/miR-145/MYO6 axis may serve as a potential therapeutic target for gastric cancer.

Citing Articles

PABPC1 Silencing Inhibits Gastric Cancer Cell Proliferation, Metastasis, and EMT Via the PI3K/AKT Pathway.

Fang J, Zhang Q, Wang Q Biochem Genet. 2024; .

PMID: 39729165 DOI: 10.1007/s10528-024-11008-9.

β-Asarone Inhibits Carboplatin Resistance in Retinoblastoma Cells Through the UCA1/miR-206/NRP1 Axis.

Bai S, Wang H, Bai Y, Liu P, Bi C Biochem Genet. 2024; .

PMID: 39718722 DOI: 10.1007/s10528-024-10985-1.

Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.

Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer.

Yang J, Zhang L, Zhu B, Wu H, Peng M Sci Rep. 2024; 14(1):18500.

PMID: 39122807 PMC: 11316077. DOI: 10.1038/s41598-024-68859-w.

Neutrophil extracellular traps-related lncRNAs prognostic signature for gastric cancer and immune infiltration: potential biomarkers for predicting overall survival and clinical therapy.

Yang S, Liang J, Wang X, Qi Y, Chan S, Song Y Discov Oncol. 2024; 15(1):291.

PMID: 39028440 PMC: 11264613. DOI: 10.1007/s12672-024-01164-0.

References

Shang C, Guo Y, Zhang J, Huang B . Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Cancer Chemother Pharmacol. 2016; 77(5):1061-7. DOI: 10.1007/s00280-016-3029-3. View

Wu J, Du M, Zhang Q, Zhang W, Fan Y, Yin L . Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145. Onco Targets Ther. 2018; 11:7483-7492. PMC: 6207254. DOI: 10.2147/OTT.S182290. View

Fayazi Hosseini N, Manoochehri H, Khoei S, Sheykhhasan M . The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study. Curr Mol Med. 2020; 21(2):96-110. DOI: 10.2174/1566524020666200619124543. View

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J . Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015; 25(8):981-4. PMC: 4528056. DOI: 10.1038/cr.2015.82. View

Qin L, Jia Z, Xie D, Liu Z . Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma. J Cell Biochem. 2018; 119(12):10075-10086. DOI: 10.1002/jcb.27344. View

Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q . Regulation of lncRNA expression. Cell Mol Biol Lett. 2014; 19(4):561-75. PMC: 6275606. DOI: 10.2478/s11658-014-0212-6. View

Yao F, Wang Q, Wu Q . The prognostic value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag Res. 2019; 11:7685-7696. PMC: 6698587. DOI: 10.2147/CMAR.S200436. View

Wei H, Qiu Y, Zeng Q, Wang S, Yi C . LncRNA UCA1 regulates proliferation, migration and invasion of cervical cancer cells by targeting miR-145. Eur Rev Med Pharmacol Sci. 2020; 24(7):3555-3564. DOI: 10.26355/eurrev_202004_20816. View

Ghafouri-Fard S, Taheri M . UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers. Biomed Pharmacother. 2019; 120:109459. DOI: 10.1016/j.biopha.2019.109459. View

10.

Wang Z, Cai Q, Hu L, He C, Li J, Quan Z . Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death Dis. 2017; 8(6):e2839. PMC: 5520878. DOI: 10.1038/cddis.2017.143. View

11.

Gu L, Lu L, Zhou D, Liu Z . UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p. Cancer Med. 2018; 7(4):1253-1263. PMC: 5911610. DOI: 10.1002/cam4.1310. View

12.

Xue M, Pang H, Li X, Li H, Pan J, Chen W . Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 2015; 107(1):18-27. PMC: 4724815. DOI: 10.1111/cas.12844. View

13.

Wang F, Yang Q . Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression. Onco Targets Ther. 2020; 13:9213-9224. PMC: 7508032. DOI: 10.2147/OTT.S249392. View

14.

Ghafouri-Fard S, Shoorei H, Tondro Anamag F, Taheri M . The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells. Front Oncol. 2020; 10:608975. PMC: 7734207. DOI: 10.3389/fonc.2020.608975. View

15.

Chen S, Luo X, Wu W, Li Y, Yu H, Wang Y . The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis. Biomed Pharmacother. 2020; 125:109986. DOI: 10.1016/j.biopha.2020.109986. View

16.

Eusebi L, Telese A, Marasco G, Bazzoli F, Zagari R . Gastric cancer prevention strategies: A global perspective. J Gastroenterol Hepatol. 2020; 35(9):1495-1502. DOI: 10.1111/jgh.15037. View

17.

Bae S, Brumbaugh J, Bonavida B . Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment. Genes Cancer. 2018; 9(3-4):87-100. PMC: 6086005. DOI: 10.18632/genesandcancer.172. View

18.

Li C, Liang G, Yang S, Sui J, Yao W, Shen X . Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway. Oncotarget. 2017; 8(55):93476-93491. PMC: 5706812. DOI: 10.18632/oncotarget.19281. View

19.

Gao Y, Wang J, Ren J, Guo M, Guo C, Ning S . Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application. World J Gastroenterol. 2020; 26(24):3401-3412. PMC: 7327794. DOI: 10.3748/wjg.v26.i24.3401. View

20.

Zhang X, Zhang W, Jiang Y, Liu K, Ran L, Song F . Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data. J Cell Biochem. 2019; 120(10):17898-17911. DOI: 10.1002/jcb.29058. View